Lin‐Lei Chen

1.4k total citations · 1 hit paper
20 papers, 520 citations indexed

About

Lin‐Lei Chen is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Lin‐Lei Chen has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Lin‐Lei Chen's work include SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (7 papers) and COVID-19 Clinical Research Studies (6 papers). Lin‐Lei Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (7 papers) and COVID-19 Clinical Research Studies (6 papers). Lin‐Lei Chen collaborates with scholars based in Hong Kong, China and United Kingdom. Lin‐Lei Chen's co-authors include Kelvin Kai‐Wang To, Kwok‐Yung Yuen, Kwok‐Hung Chan, Lu Lu, Jonathan Daniel Ip, Allen Wing‐Ho Chu, Wan-Mui Chan, Honglin Chen, Hanjun Zhao and Peng Zheng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Lin‐Lei Chen

19 papers receiving 517 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

2021 257 citations Hanjun Zhao, Lu Lu et al. Emerging Microbes & Infections profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin‐Lei Chen Hong Kong	10	418	100	64	50	44	20	520
James Logue United States	11	423 1.0×	94 0.9×	60 0.9×	67 1.3×	49 1.1×	21	554
Pinkus Tober‐Lau Germany	11	429 1.0×	158 1.6×	70 1.1×	72 1.4×	56 1.3×	27	581
Zehan Pang China	7	283 0.7×	120 1.2×	65 1.0×	62 1.2×	36 0.8×	7	447
Martin Lier Germany	5	533 1.3×	134 1.3×	35 0.5×	66 1.3×	54 1.2×	8	607
Claire Muslin Ecuador	6	320 0.8×	87 0.9×	85 1.3×	34 0.7×	46 1.0×	15	525
Yetian Dong China	4	366 0.9×	105 1.1×	38 0.6×	62 1.2×	44 1.0×	7	442
F. Akter Bangladesh	4	404 1.0×	98 1.0×	44 0.7×	28 0.6×	61 1.4×	5	553
Wendong Lan China	8	338 0.8×	148 1.5×	57 0.9×	37 0.7×	24 0.5×	9	437
Junxian Ou China	12	412 1.0×	178 1.8×	99 1.5×	41 0.8×	29 0.7×	19	563
Chunke Chen China	9	415 1.0×	158 1.6×	75 1.2×	64 1.3×	32 0.7×	16	525

Countries citing papers authored by Lin‐Lei Chen

Since Specialization

Citations

This map shows the geographic impact of Lin‐Lei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Lei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Lei Chen more than expected).

Fields of papers citing papers by Lin‐Lei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Lei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Lei Chen. The network helps show where Lin‐Lei Chen may publish in the future.

Co-authorship network of co-authors of Lin‐Lei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Lei Chen. A scholar is included among the top collaborators of Lin‐Lei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Lei Chen. Lin‐Lei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaojuan, Lin‐Lei Chen, Carol Ho-Yan Fong, et al.. (2025). Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13. The Journal of Infectious Diseases. 233(3). e662–e666.

Chen, Lin‐Lei, Xiaojuan Zhang, Kang Zhang, et al.. (2025). Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data. Emerging Microbes & Infections. 14(1). 2497304–2497304. 1 indexed citations

Zhang, Xiaojuan, Jonathan Daniel Ip, Carol Ho-Yan Fong, et al.. (2024). Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid. iScience. 27(5). 109706–109706. 5 indexed citations

Cai, Jian‐Piao, Anthony Raymond Tam, Kun Wang, et al.. (2023). Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein. SHILAP Revista de lepidopterología. 3(1). 168–168. 4 indexed citations

Fong, Carol Ho-Yan, Xiaojuan Zhang, Jonathan Daniel Ip, et al.. (2023). Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease. Scientific Reports. 13(1). 19932–19932. 4 indexed citations

Wen, Kun, Jian‐Piao Cai, Xiaojuan Zhang, et al.. (2023). Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant. Frontiers in Cellular and Infection Microbiology. 13. 1213806–1213806. 3 indexed citations

Hu, Ye‐Fan, Terrence Tsz‐Tai Yuen, Huarui Gong, et al.. (2023). Rational design of a booster vaccine against COVID-19 based on antigenic distance. Cell Host & Microbe. 31(8). 1301–1316.e8. 9 indexed citations

Chen, Lin‐Lei, Syed Muhammad Abdullah, Wan-Mui Chan, et al.. (2022). Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nature Communications. 13(1). 3618–3618. 41 indexed citations

Fong, Carol Ho-Yan, Lin‐Lei Chen, Man Lung Yeung, et al.. (2022). Interferon-gamma inhibits influenza A virus cellular attachment by reducing sialic acid cluster size. iScience. 25(4). 104037–104037. 14 indexed citations

10.

Liu, Danlei, Lu Lu, Lin‐Lei Chen, et al.. (2022). Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant. Vaccines. 10(2). 160–160. 29 indexed citations

11.

Chen, Lin‐Lei, Gilbert T. Chua, Lu Lu, et al.. (2022). Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine. Emerging Microbes & Infections. 11(1). 543–547. 49 indexed citations

12.

Zhang, Ruiqi, Danlei Liu, Yujing Fan, et al.. (2021). Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant. Vaccines. 9(12). 1442–1442. 16 indexed citations

13.

Wang, Xiaohui, Lin‐Lei Chen, Shannon Wing‐Ngor Au, et al.. (2021). Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients. Emerging Microbes & Infections. 10(1). 1016–1023. 9 indexed citations

14.

Zhao, Hanjun, Lu Lu, Peng Zheng, et al.. (2021). SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerging Microbes & Infections. 11(1). 277–283. 257 indexed citations breakdown →

15.

Chen, Lin‐Lei, Lu Lu, Jian‐Piao Cai, et al.. (2021). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination. Clinical Infectious Diseases. 74(9). 1623–1630. 40 indexed citations

16.

Poon, Rosana Wing‐Shan, Lu Lu, Carol Ho-Yan Fong, et al.. (2021). Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant. Diagnostics. 11(12). 2216–2216. 2 indexed citations

17.

Lu, Lu, Carol Ho-Yan Fong, Jinxia Zhang, et al.. (2020). Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine. Vaccines. 8(4). 754–754. 5 indexed citations

18.

Chen, Lin‐Lei, Wai‐Lan Wu, Wan-Mui Chan, et al.. (2019). Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains. Epidemiology and Infection. 147. e279–e279. 5 indexed citations

19.

Chen, Lin‐Lei, Wai‐Lan Wu, Jonathan Daniel Ip, et al.. (2019). Development and evaluation of a conventional RT‐PCR for differentiating emerging influenza B/Victoria lineage viruses with hemagglutinin amino acid deletion from B/Yamagata lineage viruses. Journal of Medical Virology. 92(3). 382–385. 5 indexed citations

20.

Dong, Hui, Xijin Ge, Yan Shen, et al.. (2009). Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE. BMC Medical Genomics. 2(1). 5–5. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact